Use of Intravenous Bisphosphonates in Early Breast Cancer

This Viewpoint assesses the use of low-dose bisphosphonates to reduce the risks of bone metastases and mortality in postmenopausal patients with early breast cancer.

https://ift.tt/2mJeOoz